HBV, HCV Reactivation During Chemotherapy of Concern Medscape Recommendations from ASCO are less comprehensive: Only those about to undergo "highly" immunosuppressive regimens (ie, stem cell transplants or treatment with rituximab) and patients "at risk" for HBV should be tested, and screening should only be for ... |
